Navigation Links
Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients
Date:9/18/2013

ROCHESTER, Minn. -- A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and glucosylceramides are metabolized. Mayo Clinic researchers have found that Parkinson's patients who do not carry the genetic mutation also have higher levels of these lipids in the blood. Further, those who had Parkinson's and high blood levels were also more likely to have cognitive impairment and dementia. The research was recently published online in the journal PLOS ONE.

The discovery could be an important warning for those with Parkinson's disease. Parkinson's is the second most common neurodegenerative disease after Alzheimer's disease. There is no biomarker to tell who is going to develop the disease -- and who is going to develop cognitive impairment after developing Parkinson's, says Michelle Mielke, Ph.D., a Mayo Clinic researcher and first author of the study.

Cognitive impairment is a frequent symptom in Parkinson's disease and can be even more debilitating for patients and their caregivers than the characteristic motor symptoms. The early identification of Parkinson's patients at greatest risk of developing dementia is important for preventing or delaying the onset and progression of cognitive symptoms. Changing these blood lipids could be a way to stop the progression of the disease, says Dr. Mielke.

There is a suggestion this blood lipid marker also could help to predict who will develop Parkinson's disease and this research is ongoing.

"There is currently no cure for Parkinson's, but the earlier we catch it -- the better chance we have to fight it," says Dr. Mielke. "It's particularly important we find a biomarker and identify it in the preclinical phase of the disease, before the onset even begins."

Dr. Mielke's lab is researching blood-based biomarkers for
'/>"/>

Contact: Nick Hanson
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Blood Pressure Down Wins Gold Medal at Living Now Book Award
2. Versatile microRNAs choke off cancer blood supply, suppress metastasis
3. Pay for performance encouraged physicians to follow blood pressure guidelines
4. DrugNews: Latest Info Shows Rise in NuvaRing Lawsuits Alleging Blood Clots
5. NuvaRing Blood-Clotting Lawsuit Help: Resource4thePeople Reports Number of Cases in Consolidated Federal Litigation Increases
6. Natural Blood Pressure Treatment
7. “Natural Blood Pressure” Teaches People How to Cure Their Hypertension Naturally and Quickly – Health Review Center
8. How To Lower High Blood Pressure
9. “Natural Blood Pressure Reduction” Teaches People How To Lower Their Hypertension With Exercise – Vkoolelite
10. High-Blood-Pressure Natural Treatment
11. “Reduce and Help High Blood Pressure” Reveals to People Natural Ways to Control Their Hypertension – V kool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... The decision to relocate US Sports Football ... to make camp more accessible to campers outside of the ... Football Camp. The fields are in premier condition and the ... Mike de Surville, vice president of US Sports Camps. “In ... coaches with the passion to create a program that makes ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 With Spring’s wet ... keep the condition of their crawl spaces in mind. The ... of the most common FAQs regarding crawl space conditions and ... an answer to owners that are confused as to how ... that, “One of the most common ways is through cracks ...
(Date:2/27/2015)... Oklahoma (PRWEB) February 27, 2015 ... by the U.S. Drug Enforcement Agency (DEA). ... local organizations continue to utilize the “Take-Back” guidelines ... by the FDA. , Eufaula Prescription Drug Disposal ... 1425 Industrial Drive in Eufaula, Oklahoma as the ...
(Date:2/27/2015)... According to a Feb. 12, 2015 ... used to treat cancer by killing cancer stem cells, has ... Administration (FDA) for use in the treatment of mesothelioma.* According ... FDA to encourage the development of drugs for the treatment ... the FDA’s decision,” said Melinda Helbock, Founder of The Law ...
(Date:2/27/2015)... 2015 The report analyzes the primary ... global celiac disease market. It also assesses key players ... activities, and investments. , Celiac disease is an autoimmune ... small intestine. Celiac disease often has a genetic predisposition. ... is affected by celiac disease across the globe. When ...
Breaking Medicine News(10 mins):Health News:US Sports Camps Football Camps Announce New Contact Football Camp Northeast Location 2Health News:Crawl Space FAQs are Answered in Clean Crawls Latest Article 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3
... free time can promote headaches in children. This is ... study on risk factors, which appears in the current ... Arztebl Int 2009; 106[31-32]: 509-16). This investigation was ... and Headache" (Kinder, Jugendliche und KopfschmerzKiJuKo), in which data ...
... , , BOCA RATON, Fla., Aug. 17 ... com ), stays focused on what he knows inside and ... country about the newest techniques in cosmetic eyelid surgery. ... uptick of patients coming to him to correct and re-do blespharoplasties," said ...
... ... Week , ... Houston (Vocus) August 17, 2009 -- SuperSlow® Zone of Greater Houston has opened ... Katy Freeway, Suite 200 provides a one-on-one efficient, effective workout in a cool (68°), studio ...
... 17 After nearly four years of joint research of Houston-based ... Space Center (JSC), a senior NASA medical officer has confirmed that two ... by the astronauts of mission STS-125 of May 11, 2009 and the ... testing aboard the International Space Station. , , ...
... , , St. Jude ... lead survey of genome that identifies new genes linked to cancer risk ... 16 Scientists at St. Jude Children,s Research Hospital have identified inherited ... lymphoblastic leukemia (ALL), including a gene that may help predict drug response. ...
... online interventions now await , SUNDAY, Aug. 16 (HealthDay ... games and gossip, news and entertainment, essential information and ... as well. , A number of successful online medical ... quit smoking, lower their blood pressure and deal with ...
Cached Medicine News:Health News:Noted Cosmetic Eyelid Specialist, B. Bruce Myers MD FACS, Retains TransMedia Group to Promote His Vision 2Health News:SuperSlow Zone Opens in Bunker Hill Village 2Health News:Astronauts Test Use of Nutritional Supplements in Space 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 4Health News:Web Is Becoming One-Stop Shopping for Health Help 2Health News:Web Is Becoming One-Stop Shopping for Health Help 3
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... investigating the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... only $158.00 per share. Concerned SLXP investors are encouraged ... . The investigation focuses upon the ... proposed agreement, Salix shareholders would receive only $158.00 per ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... , WASHINGTON, Nov. 4 Sanford Wittels & Heisler, ... AtriCure, Inc., a medical device company specializing in cardiac ... with the Department of Justice (DOJ) in a qui ... interest over a five-year period. , Sanford Wittels & ...
... OAKS, Calif., Nov. 4 Amgen (Nasdaq: AMGN ... its 19th annual Amgen Award for Science Teaching Excellence ... honor extraordinary science teachers at the K-12 level who ... who achieve demonstrated results in student learning in communities ...
Cached Medicine Technology:Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement 2Call for Applications: The Amgen Award for Science Teaching Excellence 2Call for Applications: The Amgen Award for Science Teaching Excellence 3
... Flow rate: 80 cc/minute. ... For filtering fluids at ... table; bi-directional membrane support ... (75 psi) via prefilled ...
Non-linting, quick absorption and rounded corners. Tapered malleable handle. Dispenser carton contains 25 envelopes, each envelope contains 10 sponges packaged sterile in Tyvek peel-back pouch....
Rotating 360 degrees, 1.5 mm x 4 mm bite....
Straight, right side cutting, 1.5 mm x 4 mm bite, length of shaft 115 mm, overall length 6.3 inches....
Medicine Products: